Zydus’ generic of hormone therapy patch gets U.S. FDA nod
Zydus Lifesciences wins FDA approval for a generic Estradiol-Levonorgestrel Transdermal System, with 180-day exclusivity, targeting menopause treatment.
The Hindu asks for a subscription to read the full story. If you have one, sign in on their site.
0 comments